{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:06:35Z","timestamp":1786118795412,"version":"build-2736575974"},"reference-count":5,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1097\/yct.0b013e31806548e4","type":"journal-article","created":{"date-parts":[[2007,8,28]],"date-time":"2007-08-28T03:01:23Z","timestamp":1188270083000},"page":"181-182","source":"Crossref","is-referenced-by-count":7,"title":["Electroconvulsive Therapy and Ocular Dystonia"],"prefix":"10.1097","volume":"23","author":[{"given":"Ashish","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Hammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Egbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.","family":"Sorrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"3","key":"R1-11-20210126","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2165\/00002018-200528030-00002","article-title":"Extrapyramidal symptoms with atypical antipsychotics: incidence, prevention and management.","volume":"28","author":"Pierre","year":"2005","journal-title":"Drug Saf"},{"issue":"9","key":"R2-11-20210126","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1212\/01.WNL.0000027361.73814.0E","article-title":"Blepharospasm: recent advances.","volume":"59","author":"Hallett","year":"2002","journal-title":"Neurology"},{"issue":"2","key":"R4-11-20210126","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.yct.0000167464.79327.0d","article-title":"Remission of tardive dystonia (blepharospasm) after electroconvulsive therapy in a patient with treatment-refractory schizophrenia.","volume":"21","author":"Sineaert","year":"2005","journal-title":"J ECT"},{"issue":"2","key":"R6-11-20210126","first-page":"89","article-title":"Management of Parkinson's disease a review of current and new therapies.","volume":"26","author":"Mendis","year":"1999","journal-title":"Can J Neurol Sci"},{"issue":"4","key":"R8-11-20210126","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0987-7053(96)85003-9","article-title":"Mechanism of action, clinical indication and results of treatment of botulinum toxin.","volume":"26","author":"Lagueny","year":"1996","journal-title":"Neurophysiol Clin"}],"container-title":["The Journal of ECT"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00124509-200709000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:00:15Z","timestamp":1786035615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00124509-200709000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/yct.0b013e31806548e4","relation":{},"ISSN":["1095-0680"],"issn-type":[{"value":"1095-0680","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}